CN Stock MarketDetailed Quotes

Nanjing Hicin Pharmaceutical (300584)

Watchlist
  • 38.06
  • -0.54-1.40%
Market Closed May 20 15:00 CST
4.57BMarket Cap102.86P/E (TTM)

Nanjing Hicin Pharmaceutical (300584) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Cardio-cerebrovascular class563.55M83.98%
Antibiotics35.37M5.27%
锂电池电解液添加剂27.65M4.12%
APIs and intermediates9.94M1.48%
Antiviral class9.67M1.44%
Digestive class7.85M1.17%
Immune regulatory class5.43M0.81%
Other5.25M0.78%
Other classes3.82M0.57%
Other2.52M0.38%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry638.14M95.10%
Lithium electrical material industry27.65M4.12%
Other5.25M0.78%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China region256.82M38.27%
North China187.39M27.93%
South China64.35M9.59%
Central China62.59M9.33%
Southwest area46.84M6.98%
Northwest region29.86M4.45%
Northeast area23.2M3.46%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More